Browse studies, page 10
Page 10 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Drug properties of fosravuconazole L-lysine ethanolate (NAILIN® Capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2019
- Kidney injury associated with fosravuconazole L-lysine ethanolate Clinical and experimental nephrology, 2025
- New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial The Lancet. Infectious diseases, 2021
- 爪真菌症の治療における新規経口トリアゾール系抗真菌薬であるfosravuconazole L-lysine ethanolate付加物の有効性と安全性 多施設共同二重盲検無作為化第III相試験(Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study) The Journal of dermatology, 2018
- Treatment Outcome with Fosravuconazole for Onychomycosis Mycopathologia, 2021
- Outcome of fosravuconazole treatment for onychomycosis refractory to topical antifungal agents The Journal of dermatology, 2023
- Diagnosis of Onychomycosis and Real-World Data of Oral Fosravconazole in Japan Medical mycology journal, 2025
- Actualización en el tratamiento de Helicobacter pylori: revisión del LATAMGCHMSG Revista de Gastroenterología del Perú, 2024
- Gastrin and cholecystokinin 2 receptor, and gastrin-releasing peptide receptor in cancer: From pathogenesis to precision medicine Biomedicine & Pharmacotherapy, 2026
- Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells International Journal of Molecular Sciences, 2025
- Comprehensive review of diabetes mellitus: Pathophysiology, current management, and emerging therapeutic approaches International Journal of Pharmacy and Pharmaceutical Science, 2025
- 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) European Journal of Clinical Pharmacology, 2022
- Gut microbiota in dysmenorrhea: causal evidence from Mendelian randomization and microbial-targeted intervention validation Frontiers in Microbiology, 2026
- Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans Pharmaceutics, 2023
- Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions EBioMedicine, 2023
- Interactions between reproductive biology and microbiomes in wild animal species Animal Microbiome, 2021
- Analysis of clinical characteristics and risk factors for digestive system manifestations in rheumatic diseases Srpski arhiv za celokupno lekarstvo, 2026
- Comparing vonoprazan to high-dose proton pump inhibitors for refractory gastroesophageal reflux disease Insights-Journal of Health and Rehabilitation, 2026
- Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Medicine, 2023
- Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy Diagnostics, 2023
- Psychological stress and gut microbiota regulation of osteoarthritis progression: mechanisms and therapeutic strategies Frontiers in microbiology, 2026
- Dislocation of the fibular head in an unusual sports injury: a case report Journal of Medical Case Reports, 2008
- Metallic Air Pollutants and Breast Cancer Risk in a Nationwide Cohort Study Epidemiology, 2019
- Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): A Multi-center Prospective Cohort Study Stroke, 2019
- Sex and survival in non-small cell lung cancer: A nationwide cohort study PLoS ONE, 2019
- Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: A cohort study and systematic review Journal of Neurological Sciences, 2019
- Dissecting the genetic basis of focal cortical dysplasia: a large cohort study Acta Neuropathologica, 2019
- Ultra-Processed Food Consumption Is Associated with Abdominal Obesity: A Prospective Cohort Study in Older Adults Nutrients, 2020
- Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study The Lancet, 2019
- Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study BMC Pulmonary Medicine, 2020
- Stress related disorders and risk of cardiovascular disease: population based, sibling controlled cohort study British medical journal, 2019
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study British medical journal, 2018
- Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers BMC Cancer, 2020
- Oral Anticoagulant and Reduced Risk of Dementia in Patients with Atrial Fibrillation: A Population-Based Cohort Study Heart Rhythm, 2020
- Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study JAMA Oncology, 2019
- Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study Annals of Intensive Care, 2020
- Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study Clinical Infectious Diseases, 2020
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study Lancet Neurology, 2020
- Ultra-processed food consumption and type 2 diabetes incidence: A prospective cohort study Clinical Nutrition, 2020
- Molecular and Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae in the United States: a Prospective Cohort Study Lancet. Infectious Diseases (Print), 2020
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank BMC Medicine, 2020
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study Lancet Neurology, 2013
- Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study Proceedings of the National Academy of Sciences of the United States of America, 2021
- Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study Hepatology, 2021
- Strong Reduction of Colorectal Cancer Incidence and Mortality After Screening Colonoscopy: Prospective Cohort Study From Germany American Journal of Gastroenterology, 2021
- Perioperative ctDNA-based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1) Clinical Cancer Research, 2021
- Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study Intensive Care Medicine, 2021
- Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asians — results from the UK Biobank prospective cohort study Circulation, 2021
- Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study The Lancet Haematology, 2021
- Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study Cardiovascular Diabetology, 2022
- Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study The Lancet Child & Adolescent Health, 2022
- Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study British medical journal, 2021
- Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study Clinical Rheumatology, 2023
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study The Lancet, 2021
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Lancet. Infectious Diseases (Print), 2020
- Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial American Journal of Transplantation, 2016
- Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial Journal of Clinical Endocrinology and Metabolism, 2019
- Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial American Journal of Otolaryngology, 2021
- Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature Systematic Reviews, 2020
- Uptake of Potassium-Competitive Acid Blockers Following Its Introduction in South Korea Journal of Pharmacoepidemiology and Risk Management, 2025
- Analytical method development and validation of gastrointestinal drug in bulk and pharmaceutical dosage form International Journal of Drug Delivery Technology, 2026
- Aqbd assisted development and validation of stability indicating RP-hplc method for the determination of fexuprazan hydrochloride in its tablet dosage form Zenodo (CERN European Organization for Nuclear Research), 2026
- Evaluation of the Potential Drug-Drug Interaction Between Aspirin and Fexuprazan in Healthy Subjects Using Mechanism-Based PK/PD Modeling Figshare, 2026
- Supplemental Material for: Research Article Efficacy of Fexuprazan-based Concomitant Therapy for Helicobacter pylori Infection Figshare, 2026
- Novel and Efficient Synthesis of Potassium-Competitive Acid Blocker Fexuprazan Organic Process Research & Development, 2025
- A Multi-Center, Randomized, Double-Blind, Active-controlled, Phase 2, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease ClinicalTrials.gov · COMPLETED, 2018
- A Multi-Center, Randomized, Open-Label Study to Evaluate Symptom Relief and Safety After Using Fexuprazan 40 Mg Compared to Esomeprazole 40 Mg in Patients With Gastroesophageal Reflux Disease (GERD) ClinicalTrials.gov · COMPLETED, 2024
- A Multi-Center, Randomized, Double-Blind, Active-controlled, Parallel-Group, Phase 3, Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease ClinicalTrials.gov · COMPLETED, 2019
- A Multi-center, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori ClinicalTrials.gov · COMPLETED, 2025
- A Randomized, Double-blind, Placebo-controlled, Multiple-dose Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics After Intravenous DWP14012 Injection in Healthy Volunteers ClinicalTrials.gov · COMPLETED, 2022
- A Dose Block-randomized, Double-blind, Placebo- and Active-controlled, Single and Multiple Dosing, Dose-escalation Clinical Phase 1 Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers ClinicalTrials.gov · COMPLETED, 2017
- A Randomized, Open-label Study to Evaluate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2022
- A Randomized, Open-label, Three-sequence, Three-period, Multiple Dosing Crossover, Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacodynamics of DWC202202 in Combination With DWP14012 in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2023
- A Single-center, Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of DWP14012 in Healthy Japanese, Caucasian and Korean ClinicalTrials.gov · COMPLETED, 2019
- An Open-Label, Multiple-Dose Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers ClinicalTrials.gov · COMPLETED, 2020
- Editorial: deja vu all over again – let the P‐CAB wars begin. Authors' reply Alimentary Pharmacology and Therapeutics, 2023
- Potassium-Competitive Acid Blockers (P-CABS) as a New Breakthrough in the Treatment of Gastroesophageal Reflux Disease and Erosive Esophagitis : A Recent Literature Review Jurnal Kesehatan dan Kedokteran, 2025
- Bioanalytical Method Development and Validation For The Estimation of Fexuprazan Hcl in Marketed Formulations Adolescência e Saúde, 2026
- Comparing fexuprazan and rabeprazole for treating peptic ulcer: A multicenter, randomized controlled trial World Journal of Gastroenterology, 2026
- Comparative efficacy and safety of vonoprazan-based dual therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication: a GRADE-assessed systematic review and meta-analysis with trial sequential analysis Frontiers in microbiology, 2026
- Pathophysiology updates: gastroduodenal injury and repair mechanisms Current opinion in gastroenterology, 2023
- Evaluation of Rabeprazole for Gastrointestinal Protection in Acute Coronary Syndrome Patients Treated with Aspirin and Ticagrelor: A Pilot Study Yonsei medical journal, 2026
- Endoscopic swab sampling as a novel method for gastric Microbiome profiling: A pilot study compared with tissue biopsy Scientific reports, 2025
- Comparative Pharmacokinetics Study with Fexuprazan 10 mg Demonstrated Bioequivalence with the Reference Formulation, and Evaluated Pharmacokinetics at Steady State 2023
- Association Between Gastroesophageal Reflux Disease and Chronic Respiratory Symptoms: A Systematic Review of Recent Clinical Evidence and Therapeutic Implications Cureus, 2025
- Integrated Design of Experiments Approach for a Stability-indicating Rp-hplc Method of Fexuprazan Hydrochloride Research Square, 2026
- Fexuprazan for upper gastrointestinal protection in patients with ischemic stroke and gastroesophageal reflux disease (GERD) receiving antithrombotic therapy: A preliminary prospective single-arm observational Study PloS one, 2026
- Discovery of highly selective and potent CYP1B1 inhibitors for overcoming paclitaxel resistance in A549/Taxol cells European journal of medicinal chemistry, 2026
- Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects Alimentary pharmacology & therapeutics, 2018
- Pharmacological safety and real-world efficacy of the potassium-competitive acid blocker fexuprazan in cardiovascular patients receiving antithrombotic therapy: a prospective cohort study (FEXGARD) Frontiers in pharmacology, 2026
- A randomized, open-label, single-dose study to evaluate the safety and pharmacokinetics of two formulations containing 40 mg of fexuprazan in healthy Korean subjects International journal of clinical pharmacology and therapeutics, 2026
- Size-reduced fexuprazan 20 mg demonstrated the optimal bioavailability and bioequivalence with the reference formulation Translational and clinical pharmacology, 2023
- Preference for On-Demand Fexuprazan Therapy in Gastroesophageal Reflux Disease: A Prospective Cohort Study Journal of personalized medicine, 2025
- Randomized Multicenter Study to Evaluate the Efficacy and Safety of Fexuprazan According to the Timing of Dosing in Patients With Erosive Esophagitis Journal of neurogastroenterology and motility, 2025
- Efficacy of Fexuprazan-Based Concomitant Therapy for Helicobacter pylori Infection Digestion, 2026
- Recurrent fexuprazan-induced liver injury following unintentional re-exposure British journal of clinical pharmacology, 2025
- Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison World journal of clinical cases, 2024
- A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State Pharmaceuticals (Basel, Switzerland), 2023
- Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism ACS omega, 2024
- Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects Pharmaceutics, 2023
